These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5319065)

  • 1. [Testing a virostatic agent in persons vaccinated with poliomyelitis viruses].
    Alexander M; Eggert E
    Zentralbl Bakteriol Orig; 1964 Jun; 193(1):40-7. PubMed ID: 5319065
    [No Abstract]   [Full Text] [Related]  

  • 2. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
    Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B
    Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious diseases. Report concludes polio drugs are needed--after disease is eradicated.
    Couzin J
    Science; 2006 Mar; 311(5767):1539. PubMed ID: 16543427
    [No Abstract]   [Full Text] [Related]  

  • 4. WHO recommendation on potential use of new poliomyelitis vaccines.
    Ghendon Y
    Dev Biol Stand; 1993; 78():133-7; discussion 138-9. PubMed ID: 8388823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral therapeutic intervention in poliomyelitis-like syndrome.
    Arya SC
    Brain Dev; 1999 Dec; 21(8):567; author reply 568. PubMed ID: 10598062
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [STUDIES ON POLIOMYELITIS-VACCINATED CHILDREN AFTER TREATMENT WITH AN ANTIVIRAL AGENT].
    ALEXANDER M; EGGERT E
    Verh Dtsch Ges Inn Med; 1964; 70():998-1001. PubMed ID: 14294351
    [No Abstract]   [Full Text] [Related]  

  • 8. Transmission of live vaccine viruses from vaccinated persons to others.
    Santoshkumar A
    Indian Pediatr; 2000 Jul; 37(7):794-5. PubMed ID: 10906817
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on new attenuated strains of type III live poliomyelitis vaccine. II. Field trials of Zhong III2 virus.
    Chin Med J (Engl); 1980 Sep; 93(9):591-8. PubMed ID: 6253237
    [No Abstract]   [Full Text] [Related]  

  • 10. A case for developing antiviral drugs against polio.
    Collett MS; Neyts J; Modlin JF
    Antiviral Res; 2008 Sep; 79(3):179-87. PubMed ID: 18513807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulation of the poliovirus in endemic zones with children vaccinated by the oral polio vaccine].
    Gouandjika I; Rakoto Andrianarivelo M; Akoua-Koffi C; Zeller H; Ehouman A; Morvan JM
    Bull Soc Pathol Exot; 2000 Jul; 93(3):198-201. PubMed ID: 11030057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical and safety considerations for the use in clinical trials of new attenuated poliovirus strains.
    Horaud F
    Dev Biol Stand; 1993; 78():149-54; discussion 154-5. PubMed ID: 8388825
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunization with oral poliovirus vaccine in China.
    Dong DX
    Rev Infect Dis; 1984; 6 Suppl 2():S431. PubMed ID: 6740087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania.
    Combiescu M; Guillot S; Persu A; Baicus A; Pitigoi D; Balanant J; Oprisan G; Crainic R; Delpeyroux F; Aubert-Combiescu A
    Arch Virol; 2007; 152(4):727-38. PubMed ID: 17195957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.
    Khetsuriani N; Prevots DR; Quick L; Elder ME; Pallansch M; Kew O; Sutter RW
    J Infect Dis; 2003 Dec; 188(12):1845-52. PubMed ID: 14673763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imported vaccine-associated paralytic poliomyelitis--United States, 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Feb; 55(4):97-9. PubMed ID: 16456525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increase of the titration of antibodies in children vaccinated by oral route against poliomyelitis and the transmission of attenuated viruses in persons in contact with the vaccinated child].
    HAKIM B
    Folia Clin Int (Barc); 1962 Dec; 12():557-66. PubMed ID: 13952023
    [No Abstract]   [Full Text] [Related]  

  • 19. Excretion of attenuated polioviruses in children vaccinated with live oral poliovirus vaccine.
    Kucharská Z; Srámová H; Zdrazílek J
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(1):74-82. PubMed ID: 6282962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
    Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H
    J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.